# Kinney Drugs just yanked their AI phone assistant after hundreds > Source: > Published: 2026-08-10 15:29:27+00:00 # Kinney Drugs just yanked their AI phone assistant after hundreds This feels like a classic case of deploying a tool before the prompt engineering was actually battle-tested for real-world edge cases. Most companies treat AI deployment as a "ship it and fix it" process, but in a pharmacy setting, that's a gamble. I suspect the bot struggled with the nuances of medical terminology or simply couldn't handle the frustration of callers who just wanted a human. It’s a reminder that an LLM agent is only as good as its grounding data and its ability to hand off to a human the second things go south. If I were auditing this AI workflow, I'd be looking at the fallback triggers. A successful deployment in a high-stakes environment needs a "panic button" where the AI detects sentiment shift—like anger or confusion—and immediately routes the call to a pharmacist. If Kinney Drugs just let the bot loop through its script while a customer grew more irritated, they basically built a frustration machine. For those of us building similar systems, this is a great case study for a practical tutorial on "graceful failure." You can't just prompt the AI to "be helpful"; you have to build hard constraints into the orchestration layer. For example, if the AI can't resolve a query in two turns, it should be forced to escalate. The irony is that AI assistants *should* make these calls faster by handling the routine stuff (like checking if a prescription is ready), but when they fail, they create more work for the staff who then have to deal with an already angry customer. It's a cautionary tale about the gap between a demo that works in a lab and a real-world deployment that survives the public. We're seeing this a lot lately where the "efficiency" gain for the company becomes a "friction" point for the user. Moving forward, the focus needs to be on hybrid models where AI supports the human rather than trying to replace the front line entirely. [Next AI companies are living on investor hype instead of actual →](/en/news/5793/)